← Open Payments lookup

PAOLA LUNA: Open Payments

NPI 1770142507 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,867 in 128 payments from 18 companies in 2025. Trend: 2023 $2,213 · 2024 $2,659 · 2025 $2,867

Food & beverage: $2,867
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$417
Bayer Healthcare Pharmaceuticals Inc.17$363
Novo Nordisk Inc8$250
Abbott Laboratories4$250
Lilly USA, LLC20$244
Ardelyx, Inc.9$231
ABBVIE INC.9$210
GlaxoSmithKline, LLC.11$189
Madrigal Pharmaceuticals7$173
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$136

Products named: Kerendia, FARXIGA, MOUNJARO, IBSRELA, ESPRIT, TRELEGY ELLIPTA, REZDIFFRA, Ozempic.

Industry payments across TX — which companies pay providers there.